首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   148179篇
  免费   12538篇
  国内免费   6710篇
耳鼻咽喉   1396篇
儿科学   2378篇
妇产科学   3236篇
基础医学   15966篇
口腔科学   3020篇
临床医学   17899篇
内科学   24247篇
皮肤病学   1798篇
神经病学   8427篇
特种医学   4947篇
外国民族医学   40篇
外科学   16093篇
综合类   19637篇
现状与发展   20篇
一般理论   38篇
预防医学   11186篇
眼科学   3868篇
药学   14835篇
  116篇
中国医学   6582篇
肿瘤学   11698篇
  2024年   349篇
  2023年   1789篇
  2022年   4150篇
  2021年   5742篇
  2020年   4226篇
  2019年   3998篇
  2018年   4287篇
  2017年   3966篇
  2016年   3593篇
  2015年   5627篇
  2014年   7224篇
  2013年   7757篇
  2012年   11272篇
  2011年   12060篇
  2010年   8151篇
  2009年   6794篇
  2008年   8859篇
  2007年   8996篇
  2006年   8614篇
  2005年   8009篇
  2004年   6041篇
  2003年   5566篇
  2002年   4797篇
  2001年   3312篇
  2000年   3054篇
  1999年   2898篇
  1998年   1552篇
  1997年   1475篇
  1996年   1171篇
  1995年   1130篇
  1994年   1064篇
  1993年   689篇
  1992年   1037篇
  1991年   929篇
  1990年   803篇
  1989年   716篇
  1988年   698篇
  1987年   576篇
  1986年   507篇
  1985年   413篇
  1984年   333篇
  1983年   332篇
  1982年   243篇
  1981年   242篇
  1980年   217篇
  1979年   224篇
  1978年   198篇
  1977年   180篇
  1976年   129篇
  1974年   164篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
PURPOSE: This study aims to determine the effect of loss of breast cancer metastasis suppressor 1 (BRMS1) protein expression on disease-free survival in breast cancer patients stratified by estrogen receptor (ER), progesterone receptor (PR), or HER2 status, and to determine whether loss of BRMS1 protein expression correlated with genomic copy number changes. EXPERIMENTAL DESIGN: A tissue microarray immunohistochemical analysis was done on tumors of 238 newly diagnosed breast cancer patients who underwent surgery at the Cleveland Clinic between January 1, 1995 and December 31, 1996, and a comparison was made with 5-year clinical follow-up data. Genomic copy number changes were determined by array-based comparative genomic hybridization in 47 breast cancer cases from this population and compared with BRMS1 staining. RESULTS: BRMS1 protein expression was lost in nearly 25% of cases. Patients with tumors that were PR negative (P=0.006) or HER2 positive (P=0.039) and <50 years old at diagnosis (P=0.02) were more likely to be BRMS1 negative. No overall correlation between BRMS1 staining and disease-free survival was observed. A significant correlation, however, was seen between loss of BRMS1 protein expression and reduced disease-free survival when stratified by either loss of ER (P=0.008) or PR (P=0.029) or HER2 overexpression (P=0.026). Overall, there was poor correlation between BRMS1 protein staining and copy number status. CONCLUSIONS: These data suggest a mechanistic relationship between BRMS1 expression, hormone receptor status, and HER2 growth factor. BRMS1 staining could potentially be used in patient stratification in conjunction with other prognostic markers. Further, mechanisms other than genomic deletion account for loss of BRMS1 gene expression in breast tumors.  相似文献   
92.
High cord blood immunoglobulin E (cbIgE) is known to be associated with increased risks of atopic diseases in childhood. The relationship between genetic polymorphisms and high cbIgE has not been well documented. A cross-sectional study was conducted to assess the association between cbIgE and genetic polymorphisms of interleukin (IL)-4 -590C/T, the beta-subunit of the high-affinity receptor for IgE (FcepsilonRI-beta) E237G, lymphotoxin (LT)-alphaNcoI alleles, and tumor necrosis factor (TNF)-alpha -308G/A. A total of 320 mother-neonate pairs were recruited from four maternity hospitals from different locations of Taiwan. Cord blood was obtained and assayed for cbIgE. Polymerase chain reaction followed by restriction fragment length polymorphism was used to assess the genotypes. Three hundred pairs of mothers and neonates were included in the final analysis. Infants with IL-4 -590 C allele were found to have higher risk of elevated cbIgE (> or =0.35 IU/ml, 24.3%) (p = 0.004). After adjusting for gender, birth order, maternal age, and history of allergic disease in maternal and paternal families, odds ratios for CC and CT genotypes were 4.41 and 3.16 (95% confidence interval 0.78-22.67, and 1.66-6.13), respectively, using TT genotype as reference. The genotypes of FcepsilonRI-beta, LT-alpha, and TNF-alpha were not associated with cbIgE before or after the adjustment. Our finding suggested a significant association of cbIgE with genetic polymorphism of IL-4 -590C/T, but not with the genotypes of FcepsilonRI-beta, LT-alpha, and TNF-alpha.  相似文献   
93.
94.
目的 探讨应用显微外科技术延迟一期修复四肢外周神经损伤的治疗体会。方法 应用显微外科技术延迟一期修复各种原因所致的四肢外周神经损伤38例41条,手术方法包括神经瘢痕松解、神经直接缝合术等。结果 术后随访6个月~7年,平均33个月,优良率为81.6%。结论 对失去一期修复手术治疗机会的周围神经损伤患者应尽早行延迟一期手术,可取得较好疗效。  相似文献   
95.
指背腱膜的解剖学研究   总被引:1,自引:1,他引:0  
目的 探讨指背腱膜的构成特点及临床意义。方法 在30只成人尸体手标本上,通过模拟手术,对指背腱膜的构成特点进行了应用解剖学观测。结果 指背腱膜的构成复杂,其中的外侧腱束、外侧束、外侧腱和中央束在手指畸形的发生中有着特殊的临床意义。外侧腱束主要形成伸近节指间关节的功能解剖机制;其与外侧束形成的密切纤维联系而具有协同外侧腱的功能;该腱束与屈肌腱鞘有联系又使其具有平衡屈肌和伸肌肌力的作用。中央束在指背腱膜的整体协调、畸形的发生及矫正过程中起着重要的功能。结论 通过对指背腱膜的解剖研究,可以解释因指屈、伸肌腱平衡被破坏后所形成的畸形。  相似文献   
96.
复发性鼻腔及鼻窦恶性肿瘤的挽救性治疗   总被引:1,自引:0,他引:1  
目的 探讨鼻腔及鼻窦恶性肿瘤复发后的临床表现、与复发有关的因素、再手术的意义及缺损组织的修复。方法 排除原发性鼻腔鼻窦恶性肿瘤,仅收集治疗后复发并且有再手术意义的病例。应用乘积极限法估计生存率,Stata7.0统计软件进行统计运算。结果 1993~2002年共有25例患者符合要求。男19例,女6例,年龄13~66岁,平均46.1岁。所有患者均有至少1次手术或放射治疗史。末次治疗至复发的时间2周~46个月,中位时间18个月,80%的患者肿瘤复发出现于末次治疗后2年内。术后随访1~65个月。再手术中无死亡病例。5例健在无肿瘤复发;局部复发2例,颈部淋巴结转移1例,经过1刀或手术治疗后2例健在、1例带瘤生存;死于局部复发13例,死于肺转移1例,死于无关疾病1例,失访2例。1年生存率62.5%,2年生存率43.7%,3年生存率29.1%,中位生存时间18个月。术后发生脑脊液漏3例次,中枢性尿崩症1例次,皮瓣部分坏死1例次。手术修补脑脊液漏l例。结论 鼻腔及鼻窦恶性肿瘤局部复发多发生于末次治疗后2年之内,主要症状是头痛及局部隆起。肿瘤的类型和分化程度与复发密切相关。合理、及时的综合治疗有助于减少复发。运用有效修复手段的再手术可改善晚期患者的生活质量,延长生命。并发症主要是脑脊液漏,多数可通过保守方法治愈。  相似文献   
97.
Ultrasensitive bright field in situ hybridization assays using enzyme metallography (EnzMet) have been developed and validated, but little is known regarding the applicability of EnzMet for immunophenotypic detection of protein via IHC. Superior resolution via discrete metallographic deposits offers the potential for enhancing high-resolution immunophenotyping. Using high-complexity tissue microarrays (TMAs), 88 common solid tumors were evaluated by automated EnzMet (Nanoprobes and Ventana). Targets were chosen to assess the ability of EnzMet to specifically localize encoded antigens in the nucleus (estrogen receptor), cytoplasm (cytokeratins), and cytoplasmic membrane (HER2) in TMAs. Results were compared with conventional IHC diaminobenzidine (DAB) immunostaining. There was full concordance between the EnzMet and conventional IHC results. Furthermore, the EnzMet reaction products did not appreciably diffuse, were dense and sharply defined, and provided excellent high-resolution differentiation of cellular compartments in paraffin sections for the nuclear, cytoplasmic, and cell membrane-localized antigens evaluated. The higher density of elemental silver deposited during enzyme metallography permitted evaluation of core immunophenotypes at a relatively low magnification, allowing more tissue to be screened in an efficient manner. This preliminary study shows the utility of using enzyme metallography for high-resolution immunophenotyping in TMAs.  相似文献   
98.

Background  

Colorectal cancer, if detected early, has greater than 90% 5-year survival. However, survival has been shown to vary across racial/ethnic groups in the United States, despite the availability of early detection methods.  相似文献   
99.
金真林燕玲  林静仪 《护理研究》2006,20(10):2666-2667
[目的]探讨重症肌无力病人规范化健康教育的效果。[方法3将88例重症肌无力住院病人随机分为两组,规范化健康教育组46例.和传统健康教育组42例,分别实施规范化健康教育和传统的健康教育,并进行效果评价。[结果]出院2个月后规范化健康教育组在生理职能、一般健康状态、社会功能、情感职能、精神状态方面评分明显高于传统健康教育组,两组比较有统计学意义。[结论]规范化健康教育能提高重症肌无力病人自我管理和自我调护的能力,有效达到预防疾病复发、提高生存质量的目的。  相似文献   
100.
A patient with skeletal Class III malocclusion was treated in 2 phases during the early permanent dentition. In phase 1, maxillary protraction was combined with rapid palatal expansion; in phase 2, fixed appliances were placed. The results were good posttreatment, and, 1 year later, a favorable growth tendency could be observed. This report shows that treatment for a patient with skeletal Class III malocclusion can be started in the early permanent dentition, with very good final results.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号